DIRECTORS’ REPORT FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2025 DIRECTORS’ INTERESTS The interests and deemed interests in the ordinary shares and options over shares of the Company and of its related corporations (other than wholly-owned subsidiaries) of those who were Directors at financial year end (including the interests of the spouses or children of the Directors who themselves are not Directors of the Company) as recorded in the Register of Directors’ Shareholdings are as follows: Number of ordinary shares At At 1.1.2025 Bought Sold 31.12.2025 Interests in the Company: Datuk Johar bin Che Mat - Direct 319,550 - - 319,550 Mohd Isa bin Ismail - Direct 50,000 - - 50,000 - Indirect* 455,000,000 27,500,000 - 482,500,000 * 386,500,000 ordinary shares registered in the name of Arcadia Acres Sdn. Bhd. * 96,000,000 ordinary shares registered in the name of Annedjma Capital Sdn. Bhd. Number of options over ordinary shares At 1.1.2025 Granted Forfeited/ Lapsed At 31.12.2025 Interests in the Company: Tan Sri Dato’ Sri Haji Syed Zainal Abidin bin Syed Mohamed Tahir 25,000,000 - - 25,000,000 Datuk Johar bin Che Mat 1,685,450 - - 1,685,450 Dr. Chen, Wei-Ming 1,500,000 - - 1,500,000 Chandramohan Subramaniam 1,500,000 - - 1,500,000 Zalina binti Shaher 1,500,000 - - 1,500,000 None of the other Directors holding office at 31 December 2025 had any interest in the ordinary shares and options over shares of the Company and of its related corporations during the financial year. DIRECTORS’ BENEFITS Since the end of the previous financial year, no Director of the Company has received nor become entitled to receive any benefit (other than directors’ remuneration as disclosed in the “Directors’ remuneration” of this report) by reason of a contract made by the Company or a related corporation with the Director or with a firm of which the Director is a member, or with a company in which the Director has a substantial financial interest. There were no arrangements during and at the end of the financial year which had the object of enabling Directors of the Company to acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate apart from the issue of the Employee Share Option Scheme (“ESOS”). DNeX INTEGRATED REPORT 2025 126 ABOUT THIS REPORT LEADERSHIP VALUE CREATION @DNeX LEADERSHIP INSIGHTS OVERVIEW OF DAGANG NeXCHANGE BERHAD
RkJQdWJsaXNoZXIy NDgzMzc=